2) low molecular weight heparin
低分子肝素
1.
Intra-articular low molecular weight heparin injections in treating knee osteoarthritis of rabbits;
关节腔注射低分子肝素治疗兔膝骨关节炎的研究
2.
The curative effect observation on the treatment of transient ischemic attack(TIA) with the Polivy combined with the low molecular weight heparin;
波利维联合低分子肝素治疗短暂性脑缺血发作疗效观察
3.
Study on relationship between molecular weight and anticoagulant effect of low molecular weight heparins;
低分子肝素相对分子质量与抗凝活性关系研究
3) LMWH
低分子肝素
1.
Selection of the formula for the buccal tablets under lingua of LMWH and observation of the pharmacodynamics;
低分子肝素舌下含片处方筛选及其药效观察
2.
Combination of tirofiban and LMWH for the treatment of acute in-stent thrombosis in patients with acute myocardial infarction;
替罗非班联合低分子肝素对急性心肌梗死介入治疗中急性血栓形成的影响
3.
Effect of low molecular weight heparin(LMWH) and clopidogrel on transient ischemic attack(TIA).;
低分子肝素联合氯吡格雷治疗短暂性脑缺血发作疗效观察
4) low molecular weight heparins
低分子肝素
1.
The clinical study for the patients with unstable angina with low molecular weight heparins;
低分子肝素治疗不稳定性心绞痛疗效观察
2.
The evaluation of clinical trials on different low molecular weight heparins in the efficacy of treatment in patients with acute coronary syndromes;
临床试验对不同低分子肝素在急性冠状动脉综合征治疗效果的评价
3.
Clinical study of low molecular weight heparins in treatment of chronic pulmonary heart diseases;
低分子肝素治疗慢性肺源性心脏病合并高凝状态的临床研究
5) Low-molecular-weight heparin
低分子肝素
1.
Effectiveness and impact of different dosages of low-molecular-weight heparin on nailfold microcirculation in patients with cerebral infarction;
不同剂量低分子肝素对脑梗死患者甲襞微循环的影响及疗效观察
2.
Clinical study of aspirin batroxobin combined with low-molecular-weight heparin in patients with acute cerebral infarction;
阿司匹林、巴曲酶联合低分子肝素治疗急性脑梗死的临床研究
3.
Effective evaluation of Low-Molecular-Weight heparin in combination with unite Ozagrel sodium on treating patients of acute brain infarct
低分子肝素联合奥扎格雷钠治疗急性脑梗死疗效评价
6) Low molecular heparin
低分子肝素
1.
The mechanisms of low molecular heparin in relieving pulmonary fibrosis in rats;
低分子肝素减轻大鼠肺纤维化机制探讨
2.
Research progress on low molecular heparin subcutaneous injection method;
低分子肝素皮下注射方法研究进展
3.
Clinical Analysis of Low Molecular Heparin in Curing Unstable Angina Pectoris;
低分子肝素治疗不稳定型心绞痛临床分析
补充资料：肝素化
分子式：
CAS号：
性质：足量肝素达到全身性适度抗凝的治疗方法。主要用于诊断明确、出血症状严重、病因不能迅速控制的播散性血管内凝血(DIC),以阻止血管内血液凝固的继续发展、纤维蛋白原和其他凝血因子的消耗和继发出血或出血加重。一般采用静脉滴注肝素。使用期间需监测凝血机能,随时调整剂量。肝素的抗凝作用与抗凝血酶III(AT—III)有关,当血浆AT—III活性降低,其作用也相应下降。体外循环、急性肾功能衰竭进行血液透析时也需进行全身性肝素化,不同病情时的肝素化方案各异。
CAS号：
性质：足量肝素达到全身性适度抗凝的治疗方法。主要用于诊断明确、出血症状严重、病因不能迅速控制的播散性血管内凝血(DIC),以阻止血管内血液凝固的继续发展、纤维蛋白原和其他凝血因子的消耗和继发出血或出血加重。一般采用静脉滴注肝素。使用期间需监测凝血机能,随时调整剂量。肝素的抗凝作用与抗凝血酶III(AT—III)有关,当血浆AT—III活性降低,其作用也相应下降。体外循环、急性肾功能衰竭进行血液透析时也需进行全身性肝素化,不同病情时的肝素化方案各异。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条